Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.536,38
1,03%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Atossa Therapeutics Inc (ATOS) Atossa Therapeutics Inc (ATOS) Notizie

Atossa Therapeutics Inc

ATOS
1,66
0,14 (9,21%)
03 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
29/4/202414:30GLOBEAtossa Therapeutics Announces Expanded Research Agreement..
15/4/202414:30GLOBEAtossa Therapeutics and Quantum Leap Healthcare Announce..
11/4/202414:30GLOBEAtossa to Participate in Noble Capital Markets Emerging..
09/4/202417:59GLOBEAtossa Therapeutics Presents Data from 40mg Cohort of Phase..
01/4/202422:00GLOBEAtossa Therapeutics Announces Year-End 2023 Financial..
19/3/202413:30GLOBEAtossa Therapeutics Provides Five-Year (Z)-Endoxifen..
18/3/202413:30GLOBEAtossa Therapeutics Regains Compliance with Nasdaq Minimum..
12/3/202413:30GLOBEAtossa Therapeutics Appoints Breast Cancer Specialist Tessa..
22/2/202414:30GLOBEAtossa Therapeutics Announces First Patient Dosing of..
07/2/202414:30GLOBEAtossa Therapeutics Announces Full Enrollment..
09/1/202414:30GLOBEAtossa Therapeutics Issues Letter to Shareholders
04/12/202314:30GLOBEAtossa Therapeutics Announces the Appointment of Arezoo..
20/11/202314:30GLOBEAtossa Therapeutics Announces Full Enrollment of Phase 2..
15/11/202323:03EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
15/11/202322:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
15/11/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202315:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202315:00EDGAR2Form 8-K - Current report
13/11/202315:00GLOBEAtossa Therapeutics Announces Third Quarter 2023 Financial..
09/11/202315:00EDGAR2Form 8-K - Current report
09/11/202315:00GLOBEAtossa Therapeutics Appoints Financial Executive Jonathan..
30/10/202318:00PRNUSQuantum Leap Healthcare Collaborative Initiates Landmark..
16/10/202322:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/10/202314:30PRNUSFast-food consumption by adolescent girls may sow the seeds..
06/10/202322:00EDGAR2Form 8-K - Current report
28/9/202322:28EDGAR2Form 8-K - Current report
18/9/202314:30GLOBEAtossa to Present at Cantor Fitzgerald Global Healthcare..
14/8/202314:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202314:30EDGAR2Form 8-K - Current report
14/8/202314:30GLOBEAtossa Therapeutics Announces Second Quarter 2023 Financial..
08/8/202315:00GLOBEAtossa Therapeutics to Provide Business Update and Report..
20/7/202315:15GLOBEAtossa Therapeutics Receives Approval from Health Canada to..
13/7/202322:20EDGAR2Form 8-K - Current report
13/7/202322:15GLOBEAtossa Therapeutics Regains Compliance with Nasdaq Minimum..
10/7/202315:15GLOBEAtossa Therapeutics Provides Enrollment Update for Ongoing..
06/7/202315:15GLOBEAtossa Therapeutics Announces Sponsored Research Agreement..
28/6/202315:15GLOBEAtossa Therapeutics and Quantum Leap Healthcare Provide..
28/6/202315:01EDGAR2Form 8-K - Current report
27/6/202315:15GLOBEAtossa Therapeutics Announces $10M Stock Repurchase Program
22/6/202322:15GLOBEAtossa Therapeutics Announces Sponsorship of Are You Dense..
21/6/202316:13GLOBEAtossa Therapeutics Granted Additional Patent Protection for..
14/6/202315:15GLOBEAtossa to Participate in Fireside Chat at Healthcare Virtual..
12/6/202315:15GLOBEAtossa Completes Enrollment of Pharmacokinetic Run-In Cohort..
01/6/202315:10GLOBEAtossa Appoints Life Sciences Financial and Operations..
23/5/202313:00GLOBESocietal CDMO Enters Agreement With Atossa Therapeutics to..
15/5/202315:10GLOBEAtossa Therapeutics Announces First Quarter 2023 Financial..
11/5/202315:00PRNUSPhysician-Scientist Dr. Steven Quay Provides Recommendations..
09/5/202315:15GLOBEAtossa to Present a Trial in Progress Poster on its..
Apertura: 1,53 Min: 1,53 Max: 1,70
Chiusura: 1,52

La tua Cronologia

NASDAQ
ATOS
Atossa Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network